. . . . . . . . . "\"The use of Zileuton Extended-Release Tablets is contraindicated in patients with: Active liver disease or persistent hepatic function enzyme elevations greater than or equal to 3 times the upper limit of normal (>=3xULN) [see Warnings and Precautions (5) Use in Specific Populations (8.7) A history of allergic reaction to zileuton or any of the ingredients of Zileuton Extended Release Tablets (e.g., rash, eosinophilia, etc.). Active liver disease or persistent hepatic function enzyme elevations >=3 times the upper limit of normal. ( 4 5.1 History of allergic reaction to Zileuton or any of the ingredients of Zileuton Extended-Release Tablets. ( 4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "X7+BvuEhn6t7Pam8pE9RWoXjVgYaYfbQ9BDFItywvs/blGatCdU5TMO9gR4W+6o73frnCoSPDSj4KmrVnMjtAOaEmK8lPjPe3BHj1eaTtQmvOxVJZ6QT++lEmuM4lqdfw/93RRcLHFIszw7g/1uIcG5xWupEHoJceKRDpFv7dzg=" . . "2021-08-25T13:58:13.360+02:00"^^ . . . . .